Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Trial ID or NCT#
NCT02418442
Status
RECRUITING
Purpose
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Official Title
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Eligibility Criteria
Ages Eligible for Study: Younger than 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A). 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures. 3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.
Exclusion Criteria:
- 1. Greater than 21 years of age at the time of enrollment.
Investigator(s)
Joyce Hsu
Imelda Balboni
Jennifer Frankovich
Dana Gerstbacher
Rajdeep Pooni
Cathy Mei Tsin
Tzielan Lee
Elizabeth Mellins
Contact us to find out if this trial is right for you.
Contact
Joseph Benavides
View on ClinicalTrials.gov
